会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明申请
    • Gene sequence of L-rhamnose isomerase having new catalytic function and use thereof
    • 具有新催化功能的L-鼠李糖异构酶的基因序列及其应用
    • US20080010026A1
    • 2008-01-10
    • US11714887
    • 2007-03-07
    • Ken IzumoriGoro TakadaMasaaki Tokuda
    • Ken IzumoriGoro TakadaMasaaki Tokuda
    • G06F19/00
    • C12N9/90C12P19/02C12P19/24C12Y503/01014
    • In the rare sugar strategy of Izumoring (FIG. 1), it is intended to establish a reaction system of producing rare sugars of many types by acquiring an isomerase which acts on various rare aldoses and, therefore, is most efficient in producing various rare ketoses. A DNA encoding the following protein (a) or (b). The above-mentioned DNA which is L-rhamnose isomerase derived from Pseudomonas stutzerii. A protein comprising the amino acid sequence represented by SEQ ID NO:2. A process for producing a recombinant protein characterized by culturing a host cell containing an expression system that can express the above-mentioned protein in a medium and collecting a recombinant protein having an L-rhamnose isomerase activity from the thus obtained culture. A method of applying FIG. 1 to the production of a rare sugar characterized in that the location of a target rare sugar in the overall picture of monosaccharides is understood and thus the optimum production pathway on which the above protein is allowed to act is designed.
    • 在采食稀少糖的策略(图1)中,旨在通过获得作用于各种罕见的醛糖的异构酶来建立许多类型的稀有糖的反应体系,因此在生产各种稀有酮糖中是最有效的 。 编码以下蛋白质(a)或(b)的DNA。 上述提供的源自番茄假单胞菌的L-鼠李糖异构酶的DNA。 包含SEQ ID NO:2所示的氨基酸序列的蛋白质。 一种重组蛋白质的制造方法,其特征在于,在培养基中培养含有能够在培养基中表达上述蛋白质的表达系统的宿主细胞,从所得培养物中收集具有L-鼠李糖异构酶活性的重组蛋白质。 一种应用图1的方法。 1涉及生产一种罕见的糖,其特征在于,在单糖的总体图中,目标稀有糖的位置被理解,因此设计了允许上述蛋白质起作用的最佳生产途径。
    • 34. 发明授权
    • Complex crystalline sugar comprising D-psicose and D-allose and process for production of the same
    • 复合结晶糖,包括D-灵敏蛋白和D-丙氨酸及其制备方法
    • US08748589B2
    • 2014-06-10
    • US11817774
    • 2006-03-03
    • Ken IzumoriMasaaki TokudaGoro TakataKenji Morimoto
    • Ken IzumoriMasaaki TokudaGoro TakataKenji Morimoto
    • C07H1/00
    • C12P19/02C12P19/24
    • A complex crystalline sugar comprising D-psicose and D-allose and a method for producing the same are disclosed. The compositional ratio between D-psicose and D-allose in the sugar is about 1:1 to 1:4. A process for producing a complex crystalline sugar comprising D-psicose and D-allose, the process comprising producing a complex crystalline sugar comprising D-psicose and D-allose from a sugar solution containing D-psicose and p-allose and collecting the complex crystalline sugar. The solvent of the sugar solution used in the production of the complex crystalline sugar is water or a mixture of water and ethanol. The sugar solution containing D-psicose and D-allose is produced by a process comprising reacting D-psicose with L-rhamnose isomerase to convert D-psicose into D-allose. The L-rhamnose isomerase is derived from a strain (IPOD FERM BP-08593) belonging to Pseudomonas stutzeri.
    • 公开了一种复合结晶糖,其包含D-木糖和D-阿洛糖及其制备方法。 糖中D-灵糖和D-阿洛糖的组成比为约1:1至1:4。 一种制备复合结晶糖的方法,该复合结晶糖包括D-木糖和D-阿洛糖,该方法包括由含有D-木糖和对 - 阿洛糖的糖溶液制备包含D-灵敏蛋白和D-阿洛糖的复合结晶糖并收集复合结晶糖 糖。 用于生产复合结晶糖的糖溶液的溶剂是水或水和乙醇的混合物。 通过包括使D-灵芝糖与L-鼠李糖异构酶反应以将D-灵芝蛋白转化为D-丙氨酸的方法产生含有D-灵敏蛋白和D-阿洛糖的糖溶液。 L-鼠李糖异构酶衍生自属于假单胞菌(Strepomonas stutzeri)的菌株(IPOD FERM BP-08593)。
    • 38. 发明授权
    • Application of D-psicose to suppression of abnormal circadian increase in blood glucose level
    • 应用D-psicose抑制血糖水平异常昼夜节律升高
    • US08071558B2
    • 2011-12-06
    • US11909493
    • 2006-03-22
    • Masaaki TokudaKen IzumoriTatsuhiro MatsuoKenji MorimotoKaoru Takekawa
    • Masaaki TokudaKen IzumoriTatsuhiro MatsuoKenji MorimotoKaoru Takekawa
    • A61K31/7004A61P3/08
    • A23K50/40A23K20/163A23L27/30A23L33/10A61K31/7004
    • A novel use of D-psicose (for suppressing the abnormal intra-day increase of blood glucose level) is provided. A composition containing D-psicose as the active component and for use in suppressing the abnormal intra-day increase of plasma glucose concentration. The composition is a composition in blend with D-psicose and/or a derivative thereof. The composition is in a form selected from sweeteners, seasonings, food additives, food materials, food and drink products, health food and drink products, pharmaceutical products, and feeds and blended with D-psicose, and/or a derivative thereof as the active component, for use in preventing and therapeutically treating diseases requiring the saving of insufficient insulin, the amelioration of insulin sensitivity and the amelioration of hyperglycemia, and/or diseases of which the symptoms can be ameliorated via the suppression of the abnormal intra-day increase of plasma glucose concentration or of which the onset can be prevented via the suppression thereof, such as diabetes mellitus, occult diabetic states, obesity, hyperglycemia, and/or arteriosclerosis. A method for using D-psicose in suppressing the abnormal intra-day increase of plasma glucose concentration, comprising giving D-psicose at given times to suppress the abnormal increase of plasma glucose concentration throughout the day.
    • 提供了一种新的D-psicose的用途(用于抑制日内异常增加血糖水平)。 作为活性成分含有D-灵芝蛋白的组合物,用于抑制日内异常增加血浆葡萄糖浓度。 组合物是与D-灵芝蛋白和/或其衍生物共混的组合物。 该组合物为选自甜味剂,调味料,食品添加剂,食品材料,食品和饮料产品,保健食品和饮料产品,药品和饲料中的形式,并且与D-灵芝蛋白和/或其衍生物作为活性成分 组分,用于预防和治疗需要节省胰岛素不足的疾病,改善胰岛素敏感性和改善高血糖症,和/或通过抑制日内异常升高可以改善症状的疾病 血浆葡萄糖浓度或通过其抑制如糖尿病,隐匿性糖尿病状态,肥胖症,高血糖症和/或动脉硬化可以预防发作。 一种用于抑制血浆葡萄糖浓度异常日增加的方法,包括在给定时间给予D-psicose以抑制全天血浆葡萄糖浓度的异常增加。